 | • レポートコード：MRC-IM30898 • 出版社/出版日：IMARC / 2023年3月 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥369,852 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥665,852 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2022年238億ドルであった世界の血漿分画市場規模が2028年には337億ドルに達し、予測期間中（2023年-2028年）、年平均5.8％成長すると予測しています。当調査資料では、血漿分画の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品別（免疫グロブリン、アルブミン、凝固第VIII因子、凝固第IX因子）分析、分野別（民間、公共）分析、用途別（神経、免疫、血液、その他）分析、 エンドユーザー別（病院＆クリニック、臨床検査研究所、学術機関）分析、地域別（北米、アジア、欧州、中南米、中東/アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。なお、当市場の主要企業には、ADMA Biologics、Bio Products Laboratory Ltd.、Boccard、Grifols、S.A.、Hemarus Therapeutics Limited、Intas Pharmaceuticals Limited、LFB S.A.、Merck Group、Octapharma AG、PlasmaGen BioSciences Pvt. Ltd.、SK Plasma Co. Ltd. and Virchow Biotech Private Limitedなどが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の血漿分画市場規模：製品別 - 免疫グロブリンの市場規模 - アルブミンの市場規模 - 凝固第VIII因子の市場規模 - 凝固第IX因子の市場規模 ・世界の血漿分画市場規模：分野別 - 民間における市場規模 - 公共における市場規模 ・世界の血漿分画市場規模：用途別 - 神経における市場規模 - 免疫における市場規模 - 血液における市場規模 - その他用途における市場規模 ・世界の血漿分画市場規模：エンドユーザー別 - 病院＆クリニックにおける市場規模 - 臨床検査研究所における市場規模 - 学術機関における市場規模 ・世界の血漿分画市場規模：地域別 - 北米の血漿分画市場規模 - アジアの血漿分画市場規模 - 欧州の血漿分画市場規模 - 中南米の血漿分画市場規模 - 中東/アフリカの血漿分画市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global plasma fractionation market size reached US$ 23.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.
Plasma fractionation refers to the downstream processing of donated plasma into life-saving therapies and medicinal products. It breaks plasma into individual proteins or plasma fractions using mechanical separation methods, such as centrifugation, depth filtration, precipitation, and chromatography. Nowadays, several modern fractionation processes use alcohol concentrations, time, temperature, and pH to extract specific therapeutic proteins. Moreover, increasing technology complexity over the years and the introduction of in-process viral reduction treatments have resulted in the development of new protein therapeutics and improvement in product purity and quality.
Plasma Fractionation Market Trends:
Protein products fractionated from human plasma are an essential class of therapeutics widely used to prevent, manage, and treat life-threatening conditions, such as infections, congenital deficiencies, rare blood disorders, immunologic disorders, and autoimmune disorders. A significant rise in the prevalence of these conditions among a significant part of the population globally represents one of the key factors impelling the market growth. In addition, manufacturers are developing plasma fractionation with additional safety features due to the implementation of stringent regulations and standard controls and settings by governing agencies of numerous countries on quality assurance of biological products. Apart from this, market players are financing research and development (R&D) activities to launch advancement in plasma production technology to improve product efficacy and enhance recovery of immunoglobulin G (IgG) to isolate new plasma proteins. Furthermore, they are focusing on developing affordable viral inactivation and processing technologies that allow utilization of local plasma resources safely. This, in confluence with the escalating need to improve yield, maintain process economics, and manage increasing regulatory requirements, is anticipated to provide a favorable market outlook in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global plasma fractionation market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, sector, application and end user.
Breakup by Product:
Immunoglobulins
Albumin
Coagulation factor VIII
Coagulation factor IX
Breakup by Sector:
Private Sector
Public Sector
Breakup by Application:
Neurology
Immunology
Hematology
Other Applications
Breakup by End User:
Hospitals and Clinics
Clinical Research Laboratories
Academic Institutes
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd. and Virchow Biotech Private Limited.
Key Questions Answered in This Report
1. What was the size of the global plasma fractionation market in 2022?
2. What is the expected growth rate of the global plasma fractionation market during 2023-2028?
3. What has been the impact of COVID-19 on the global plasma fractionation market?
4. What are the key factors driving the global plasma fractionation market?
5. What is the breakup of the global plasma fractionation market based on the product?
6. What is the breakup of the global plasma fractionation market based on the sector?
7. What is the breakup of the global plasma fractionation market based on the application?
8. What is the breakup of the global plasma fractionation market based on the end user?
9. What are the key regions in the global plasma fractionation market?
10. Who are the key players/companies in the global plasma fractionation market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Plasma Fractionation Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Immunoglobulins
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Albumin
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Coagulation factor VIII
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Coagulation factor IX
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Sector
7.1 Private Sector
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Public Sector
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Neurology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Immunology
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Hematology
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Other Applications
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Clinical Research Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Academic Institutes
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 ADMA Biologics
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.2 Bio Products Laboratory Ltd.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Boccard
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Grifols, S.A.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Hemarus Therapeutics Limited
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Intas Pharmaceuticals Limited
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 LFB S.A.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Merck Group
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Octapharma AG
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 SWOT Analysis
15.3.10 PlasmaGen BioSciences Pvt. Ltd.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 SK Plasma Co. Ltd.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 Virchow Biotech Private Limited
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
Figure 2: Global: Plasma Fractionation Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Plasma Fractionation Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Plasma Fractionation Market: Breakup by Product (in %), 2022
Figure 5: Global: Plasma Fractionation Market: Breakup by Sector (in %), 2022
Figure 6: Global: Plasma Fractionation Market: Breakup by Application (in %), 2022
Figure 7: Global: Plasma Fractionation Market: Breakup by End User (in %), 2022
Figure 8: Global: Plasma Fractionation Market: Breakup by Region (in %), 2022
Figure 9: Global: Plasma Fractionation (Immunoglobulins) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Plasma Fractionation (Immunoglobulins) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Plasma Fractionation (Albumin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Plasma Fractionation (Albumin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Plasma Fractionation (Coagulation factor VIII) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Plasma Fractionation (Coagulation factor VIII) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Plasma Fractionation (Coagulation factor IX) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Plasma Fractionation (Coagulation factor IX) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Plasma Fractionation (Private Sector) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Plasma Fractionation (Private Sector) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Plasma Fractionation (Public Sector) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Plasma Fractionation (Public Sector) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Plasma Fractionation (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Plasma Fractionation (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Plasma Fractionation (Immunology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Plasma Fractionation (Immunology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Plasma Fractionation (Hematology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Plasma Fractionation (Hematology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Plasma Fractionation (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Plasma Fractionation (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Plasma Fractionation (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Plasma Fractionation (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Plasma Fractionation (Clinical Research Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Plasma Fractionation (Clinical Research Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Plasma Fractionation (Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Plasma Fractionation (Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: North America: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: North America: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: United States: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: United States: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Canada: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Canada: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Asia-Pacific: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Asia-Pacific: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: China: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: China: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Japan: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Japan: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: India: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: India: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: South Korea: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: South Korea: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Australia: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Australia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Indonesia: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Indonesia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Europe: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Europe: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Germany: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Germany: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: France: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: France: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: United Kingdom: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: United Kingdom: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Italy: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Italy: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Spain: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Spain: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Russia: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Russia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Latin America: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Latin America: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Brazil: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Brazil: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Mexico: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Mexico: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Middle East and Africa: Plasma Fractionation Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Middle East and Africa: Plasma Fractionation Market: Breakup by Country (in %), 2022
Figure 83: Middle East and Africa: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Global: Plasma Fractionation Industry: SWOT Analysis
Figure 85: Global: Plasma Fractionation Industry: Value Chain Analysis
Figure 86: Global: Plasma Fractionation Industry: Porter's Five Forces Analysis